Just 38% of patients with breast cancer receive at least 1 palliative care consult following metastatic disease diagnosis.
ASCO 2022: Focus on Breast Cancer
Advertisement
All stakeholders have a role to play in increasing representation in this patient population.
A study identified self-reported gaps from healthcare providers associated with providing treatment-related support.
Research has shown that weight gain and obesity can be associated with an increased risk of developing breast cancer.
Some research has shown that patients with certain autoimmune diseases have a lower risk of breast cancer.
“CTCs contribute to the metastatic cascade and represent an independent survival predictor in breast cancer."
Research has shown that women with breast cancer who live in socioeconomically disadvantaged areas have poorer outcomes.
Breast cancer that is hormone receptor (HR)-positive tends to be diagnosed early, when it is highly treatable.
The new research was presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.